Christie Edward M III 4

What Happened
Christie Edward M III, a non‑employee director of Encompass Health Corp (EHC), had two acquisition transactions reported. On April 15, 2026 he was credited with 9 restricted stock units (RSUs) related to a $0.19 per‑share dividend (reported at $0.00 cash). On April 16, 2026 he acquired 261 shares in the market under the company’s Directors Deferred Stock Investment Plan at a weighted average price of $106.17 per share for a total of $27,710. Both filings are reported as acquisitions (code A).

Key Details

• Transaction dates: April 15, 2026 (9 RSUs credited); April 16, 2026 (261 shares purchased).
• Prices/values: 9 RSUs reported at $0.00 (dividend‑credited award); 261 shares at a weighted avg $106.17; total purchase ≈ $27,710. Purchases executed in multiple trades at $106.11–$106.17.
• Shares owned after transaction: Not stated in the provided filing excerpt.
• Footnotes of note:
  • F1: The 9 RSUs were credited as additional RSUs tied to the $0.19 per‑share dividend; closing price on dividend payment date was $105.24.
  • F2: The 261 shares were bought by the plan using fees deferred by the director and include reinvested dividends.
  • F3: The $106.17 price is a weighted average (range $106.11–$106.17); full per‑lot price breakdown available on request.
• Timeliness: Filing covers activity through April 15, 2026 and was filed April 16, 2026 (appears timely).

Context
The April 15 RSU credit reflects dividend reinvestment into additional RSUs under existing awards; the April 16 acquisition was a purchase funded by deferred director fees under the Directors Deferred Stock Investment Plan. These are routine non‑employee director compensation and deferral transactions rather than open‑market discretionary buys by an executive.